SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon's stock is trending due to a widespread outage of Amazon Web Services (AWS), impacting numerous websites and services. The community is expressing frustration and speculating about the cause, ranging from technical glitches to potential cyberattacks, with some even calling for leadership changes. This outage raises concerns about the reliability of centralized cloud infrastructure and its potential impact on various sectors.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood ($HOOD) is trending as users report app outages, sparking concerns about funds and platform reliability; the issues are attributed to a broader disruption of Amazon Web Services (AWS). The community is debating the safety of their investments and considering alternative platforms amid the ongoing technical difficulties, while others point out many apps are down due to AWS.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase ($COIN) is trending as the stock is experiencing volatility amid broader market concerns and a sharp drop in Bitcoin's price. Community discussions revolve around potential market manipulation, outages, and whether the dip represents a buying opportunity or a sign of further declines, with some traders expressing frustration over the stock's price action relative to Bitcoin.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as traders discuss potential catalysts like upcoming ETF decisions and Ripple's reported plans for a $1 billion XRP treasury, though the US government shutdown has introduced uncertainty around the timing of regulatory approvals. Community members are actively debating potential price movements, with some expressing frustration about market manipulation and others emphasizing long-term potential. Some users are also reporting login issues and maintenance on major exchanges.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

CELC is trending due to positive Phase 3 trial results for its breast cancer drug, gedatolisib, showing a clinically meaningful improvement. The community is buzzing about the potential for FDA approval and the possibility of a buyout, while analysts are revising price targets upward. Discussion also includes speculation about an upcoming offering and its impact on the stock price, as well as concerns about short squeezes.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

$BULL is trending as users discuss the platform's functionality compared to alternatives like Robinhood, particularly amid reports of outages on competing platforms; the community is weighing entry points and debating the stock's short-term trajectory, with some expressing concerns about potential downside while others see a buying opportunity. Overall sentiment seems mixed, with a focus on technical levels and potential catalysts such as earnings.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is trending amid discussions of its recent acquisition of Astria Therapeutics, a move intended to bolster its hereditary angioedema (HAE) pipeline. While some investors express concerns about dilution and the risk associated with a phase 3 asset, others view it as a strategic step to dominate the HAE market. The community is also debating the impact of analyst ratings and potential algorithmic trading influences on the stock's price action.

Citigroup, Inc. is a holding company, which engages in the provision of financial products and services. It operates through the following segments: Services, Markets, Banking, Wealth, U.S. Personal Banking (USPB), and All Other. The Services segment includes Treasury and Trade Solutions (TTS) which provides an integrated suite of tailored cash management, trade, and working capital solutions to multinational corporations, financial institutions and public sector organizations, and Securities Services, which offers cross-border support for clients, providing on-the-ground local market expertise, post-trade technologies, customized data solutions, and a wide range of securities services solutions that can be tailored to meet client needs. The Markets segment provides corporate, institutional, and public sector clients around the world with a full range of sales and trading services across equities, foreign exchange, rates, spread products, and commodities. The Banking segment offers Investment Banking and Corporate Lending services. The Wealth segment includes Private Bank, Wealth at Work, and Citigold and provides financial services to a range of client segments through banking, lending, mortgages, investment, custody, and trust product offerings. The USPB segment includes Branded Cards and Retail Services, which have proprietary card portfolios and co-branded card portfolios within Branded Cards, and co-brand and private label relationships within Retail Services. The All Other segment consists of activities not assigned to the reportable operating segments, including certain unallocated costs of global functions, other corporate expenses, and net treasury results. The company was founded in 1812 and is headquartered in New York, NY.

Citigroup Inc

Citigroup ($C) is trending as analysts increase price targets following positive stress test results and news of a dividend hike and $20B share buyback program. Community chatter highlights the stock's potential, focusing on its attractive valuation relative to book value. Some traders are noting the stock's recent strength, while others are wary of overbought conditions.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercard ($MA) is trending due to a mix of options activity and broader market analysis, with community members pointing out both bullish and bearish signals. Discussions include unusual options flow, analyst ratings, and potential impacts from tariffs and competition in the payment processing space. Some are questioning if stablecoins or general economic uncertainty will affect MA's long-term growth.

NuCana Plc is a clinical stage biopharmaceutical company. It engages in the business of developing a portfolio of new medicines to treat patients with cancer. The company was founded by Hugh Stephen Griffith and Christopher Barry Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.

NuCana plc - ADR

NuCana plc

NuCana ($NCNA) is trending due to positive preclinical data on its cancer treatment NUC-7738, particularly its synergistic effects with PD-1 inhibitors. The community is discussing the potential for significant tumor reduction and a possible acquisition rumor. Investors are anticipating upcoming presentations and data releases, hoping for catalysts that could drive the stock's valuation higher given its low float.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

These Are The Cars With The Best Resale Value In 2025

These Are The Cars With The Best Resale Value In 2025 Cars are one of the most significant purchases people make, but unlike real estate, their value drops quickly. To help you protect your...

Inside Japan's New Immigration Era

With its population shrinking and its labor force aging, Japan is turning to foreign workers in record numbers. From Toyota City to factory floors across the country, immigration is testing how much...

Ex-lidar CEO makes a bid to reclaim his company

Ex-Luminar CEO Austin Russell is trying to wrest back control of his company. | Image: Andrew J. Hawkins / The Verge Earlier this year, Luminar founder and CEO Austin Russell abruptly resigned from...

Shares of General Motors and Ford fell on Thursday as major automakers warned that a deepening semiconductor disruption tied to a dispute between China and the Dutch government could soon hit U.S. and European vehicle production.<a href="https://stocktwits.com/symbol/GM">General Motors’ stock</a> slipped 0.8% to close at $57.34 on Thursday, while&nbsp;<a href="https://stocktwits.com/symbol/F">Ford’s stock</a> edged 0.2% lower to $11.74.&nbsp;Automakers Warn Of Supply Chain RisksThe European Automobile Manufacturers’ Association (ACEA) said carmakers and suppliers had been notified by chipmaker Nexperia that it could no longer guarantee deliveries, warning that manufacturing could be significantly disrupted. The notice comes as automakers already face supply-chain pressure from tariffs, foreign competition, and softening demand, according to a Reuters&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/business/autos-transportation/automaker-group-warns-nexperia-chip-supply-issue-could-quickly-disrupt-us-2025-10-17/">report</a>.In the U.S., the trade group Alliance for Automotive Innovation, whose members represent automakers such as GM and Ford as well as Toyota, Volkswagen, Hyundai, Stellantis and other companies, urged both governments to resolve the issue quickly before it worsens.&nbsp;John Bozzella, the group’s CEO, said if chip shipments don’t resume soon, auto production in the U.S. and elsewhere will be disrupted with consequences for other parts of the economy.Some automakers said that U.S. production could be affected as early as next month. The chips made by Nexperia, although not technically advanced, are produced in large volumes and are essential for manufacturing vehicle parts and components.Nexperia At Center Of DisputeThe dispute began after the Dutch government moved on Sept. 30 to take control of Nexperia, a Chinese-owned chipmaker, citing national security worries about technology potentially flowing to its parent company, Wingtech, which is already under U.S. export restrictions.&nbsp;Just days later, on Oct. 4, China’s commerce ministry struck back, blocking Nexperia’s Chinese operations and subcontractors from exporting certain parts and subassemblies.Carmakers Brace For FalloutStellantis, whose brands include Jeep, Peugeot, and Fiat, said it was collaborating with Nexperia and other suppliers to assess potential impacts and develop mitigation measures. Meanwhile, Automakers including Volkswagen and BMW said their European plants have not yet been affected but are monitoring supply chains closely.Retail-Trader Sentiment For GM, Ford SplitOn Stocktwits, retail sentiment toward General Motors was ‘bullish’, while sentiment for Ford was ‘neutral’, with both tickers seeing ‘low’ message volume.While Ford’s stock has risen 26% so far this year, General Motors’ stock has climbed 9% over the same period.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A large number of vehicles of various brands under General Motors were neatly lined up at the finished vehicle transfer base of General Motors in Shanghai, China. (Photo credit should read CFOTO/Future Publishing via Getty Images)

GM, Ford Stocks Slip As China-Dutch Chip Dispute Over Nexperia Sparks Fresh Supply Chain Fears

The dispute erupted after the Dutch government seized control of Chinese-owned Nexperia over security concerns, triggering retaliation from Beijing and raising fears of another supply shock for the auto industry.

Equity

Toyota Motor Corporation (TM) Laps the Stock Market: Here's Why

In the most recent trading session, Toyota Motor Corporation (TM) closed at $194.33, indicating a +1.35% shift from the previous trading day.

Kyle Hamilton partners with Toyota to host NFL FLAG clinic for military families at Ravens facility

Flag football has grown considerably in recent years and its origin is one that involves the U.S. military. During World War II, flag football was born at Fort Meade, the Army base in Maryland, as...

The Latest Evolution of Toyota's Multimedia Coming to a Screen Near You

The Latest Evolution of Toyota's Multimedia Coming to a Screen Near You The Latest Evolution of Toyota's Multimedia Coming to a Screen Near You PR Newswire PLANO, Texas, Oct. 13, 2025 Enhanced Toyota...

Toyota Motor Corporation (TM) Declines More Than Market: Some Information for Investors

Toyota Motor Corporation (TM) reached $192.33 at the closing of the latest trading day, reflecting a -2.97% change compared to its last close.

Is It Worth Investing in Toyota Motor (TM) Based on Wall Street's Bullish Views?

Based on the average brokerage recommendation (ABR), Toyota Motor (TM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Are Tesla's "Affordable" Models Truly Cheap and Can They Fuel Demand?

TSLA's new "affordable" Model 3 and Model Y aim to boost sales, but are the stripped-down features enough to attract budget EV buyers?

Toyota Motor Corp. engages in the manufacture and sale of motor vehicles and parts. It operates through the following segments: Automotive, Financial Services, and All Other. The Automotive segment designs, manufactures, assembles and sells passenger cars, minivans, trucks, and related vehicle parts and accessories. It is also involved in the development of intelligent transport systems. The Financial Services segment offers purchase or lease financing to Toyota vehicle dealers and customers. It also provides retail leasing through lease contracts purchased by dealers. The All Others segment deals with the design, manufacture, and sale of housing, telecommunications and other businesses. The company was founded by Kiichiro Toyoda on August 28, 1937 and is headquartered in Toyota, Japan.

Toyota Motor Corporation - ADR

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

TM
Toyota Motor Corp.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TM News

TMToyota Motor Corp.